Jump to main content
Jump to site search

Issue 31, 2017
Previous Article Next Article

Phase and morphological control of MoO3−x nanostructures for efficient cancer theragnosis therapy

Author affiliations

Abstract

Nanostructures of metal oxide semiconductors play significant roles in a variety of areas, such as biotherapy, pollutant treatment and energy storage and conversion. The molybdenum oxide (MoO3−x) nanostructures have shown promising applications especially when used as photothermal treatment agents due to their relatively low cost, facile synthesis and low toxicity. However, the design and synthesis of efficient MoO3−x nanomaterials with tunable phases and morphologies for theragnosis of tumors remains a challenge. In this work, hydrophilic MoO3−x with controlled structures and phases was synthesized by a simple one-step hydrothermal process. The as-obtained MoO2 nanoclusters showed a desirable size of ∼40 nm in diameter exhibiting unique properties as a theragnosis nanoplatform: (1) strong near-infrared absorption, which is due to oxygen vacancies of the nanoclusters, as proved by photoluminescence spectroscopy and X-ray photoelectron spectroscopy; (2) excellent photothermal performance with a photothermal conversion efficiency of up to 62.1%; and (3) the image response of X-ray computed tomography (CT) and infrared thermal imaging for simultaneous diagnosis of tumors. This study provided the facile synthetic strategy for controllable metal oxide semiconductors and promoted the development of metal oxides for theragnosis therapy of cancers.

Graphical abstract: Phase and morphological control of MoO3−x nanostructures for efficient cancer theragnosis therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 15 May 2017, accepted on 23 Jul 2017 and first published on 25 Jul 2017


Article type: Communication
DOI: 10.1039/C7NR03469E
Nanoscale, 2017,9, 11012-11016
  • Open access: Creative Commons BY license
  •   Request permissions

    Phase and morphological control of MoO3−x nanostructures for efficient cancer theragnosis therapy

    B. Li, X. Wang, X. Wu, G. He, R. Xu, X. Lu, F. R. Wang and I. P. Parkin, Nanoscale, 2017, 9, 11012
    DOI: 10.1039/C7NR03469E

    This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements